<?xml version='1.0' encoding='UTF-8' ?>
<ec-patent-document file='EC_SP17020133_20180228.xml' country='EC' doc-number='SP17020133' kind='A' date-published='20180228' lang='ES' date-produced='20190116'>
<bibliographic-data id='bibl' doc-number='SP17020133' country='EC' lang='es'>
<publication-reference><document-id ><country>EC</country><doc-number>SP17020133</doc-number><kind>A</kind><date>20180228</date></document-id></publication-reference>
<classification-ipcr><classification-ipc sequence='1'><section> </section><class> </class><subclass> </subclass><main-group> </main-group><subgroup> </subgroup><edition> </edition><ipc-version-indicator><date> </date></ipc-version-indicator><classification-level>C07D487/04,C07D519/00,A61K31/5513,A61P35/00,C07K16/28,C07K7/02</classification-level><symbol-position> </symbol-position><classification-value> </classification-value></classification-ipc></classification-ipcr>
<application-reference> <document-id><country>EC</country><doc-number>IEPI201720133</doc-number><date>20170403</date></document-id></application-reference>
<priority-claims>
<priority-claim sequence='1' kind='National'><doc-number>62/045,248</doc-number><date>20140903</date><country>US</country></priority-claim>
<priority-claim sequence='2' kind='National'><doc-number>62/087,040</doc-number><date>20141203</date><country>US</country></priority-claim>
<priority-claim sequence='3' kind='National'><doc-number>62/149,370</doc-number><date>20150417</date><country>US</country></priority-claim>
<priority-claim sequence='4' kind='National'><doc-number>62/164,305</doc-number><date>20150520</date><country>US</country></priority-claim>
</priority-claims>
<parties><applicants>
<applicant sequence='1' designation='all' app-type='applicant'><addressbook><name>IMMUNOGEN, INC.</name><address><street>830 Winter Street, Waltham, Massachusetts 02451, Estados Unidos de America</street><country>US</country></address></addressbook></applicant>
</applicants>
<inventors>
<inventor sequence='1' designation='all'><addressbook><name>MILLER, Michael Louis</name><address><street>4 Maymont Drive, Framingham, MA 01701, Estados Unidos de America</street><country>US</country></address></addressbook></inventor>
<inventor sequence='2' designation='all'><addressbook><name>UFINET TELECOM HOLDING, S.L.U.</name><address><street>Calle Manuel Silvela número 13, 28010, Madrid, España</street><country>ES</country></address></addressbook></inventor>
<inventor sequence='3' designation='all'><addressbook><name>CHARI, Ravi</name><address><street>174 Winchester Street, Newton, MA 02461, Estados Unidos de America</street><country>US</country></address></addressbook></inventor>
</inventors><agents>
<agent sequence='1' rep-type='agent'><addressbook><name>PONCE MARTINEZ, ALEJANDRO</name><address><street>AV. 12 DE OCTUBRE Y LINCOLN, TORRE 1492</street><country>EC</country></address></addressbook></agent>
</agents></parties>
<invention-title lang='es'>DERIVADOS DE BENZODIAZEPINA CITOTÓXICOS</invention-title>
</bibliographic-data>
<abstract lang='es'>La invención se refiere a derivados de benzodiazepina novedosos con actividad antiproliferativa y, más específicamente, a compuestos de benzodiazepina novedosos de fórmula (I)-(VI). La invención también proporciona conjugados de los compuestos de benzodiazepina unidos a un agente de unión celular. La invención también proporciona composiciones y métodos útiles para inhibir el crecimiento celular anormal o tratar un trastorno proliferativo en un mamífero utilizando los compuestos o conjugados de la invención.</abstract>
</ec-patent-document>
